Edition:
United Kingdom

Aerie Pharmaceuticals Inc (AERI.OQ)

AERI.OQ on NASDAQ Stock Exchange Global Market

23.12USD
19 Jul 2019
Change (% chg)

$-0.50 (-2.12%)
Prev Close
$23.62
Open
$23.62
Day's High
$23.77
Day's Low
$22.47
Volume
215,271
Avg. Vol
190,904
52-wk High
$74.75
52-wk Low
$22.47

About

Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's product candidates include Rhopressa (netarsudil ophthalmic solution) 0.02%... (more)

Overall

Beta: 0.39
Market Cap(Mil.): $1,084.58
Shares Outstanding(Mil.): 45.92
Dividend: --
Yield (%): --

Financials

  AERI.OQ Industry Sector
P/E (TTM): -- 95.83 34.03
EPS (TTM): -5.56 -- --
ROI: -83.13 7.72 12.70
ROE: -111.96 8.23 17.29

Earnings vs. Estimates